These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 25469848

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cyclosporine A induces endothelin-converting enzyme-1: Studies in vivo and in vitro.
    Heyman SN, Abassi Z, Rosenberger C, Yaseen H, Skarjinski G, Shina A, Mathia S, Krits N, Khamaisi M.
    Acta Physiol (Oxf); 2018 May; 223(1):e13033. PubMed ID: 29330945
    [Abstract] [Full Text] [Related]

  • 4. Minocycline accelerates hypoxia-inducible factor-1 alpha degradation and inhibits hypoxia-induced neovasculogenesis through prolyl hydroxylase, von Hippel-Lindau-dependent pathway.
    Li CH, Liao PL, Yang YT, Huang SH, Lin CH, Cheng YW, Kang JJ.
    Arch Toxicol; 2014 Mar; 88(3):659-71. PubMed ID: 24292262
    [Abstract] [Full Text] [Related]

  • 5. The balance of beneficial and deleterious effects of hypoxia-inducible factor activation by prolyl hydroxylase inhibitor in rat remnant kidney depends on the timing of administration.
    Yu X, Fang Y, Liu H, Zhu J, Zou J, Xu X, Jiang S, Ding X.
    Nephrol Dial Transplant; 2012 Aug; 27(8):3110-9. PubMed ID: 22399494
    [Abstract] [Full Text] [Related]

  • 6. Role of protein kinase C in the expression of endothelin converting enzyme-1.
    Khamaisi M, Dahan R, Hamed S, Abassi Z, Heyman SN, Raz I.
    Endocrinology; 2009 Mar; 150(3):1440-9. PubMed ID: 18974277
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Novel mechanism of action for hydralazine: induction of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by inhibition of prolyl hydroxylases.
    Knowles HJ, Tian YM, Mole DR, Harris AL.
    Circ Res; 2004 Jul 23; 95(2):162-9. PubMed ID: 15192023
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Establishment of hypoxia inducible factor-1alpha overexpressing cells that produce endothelin-1.
    Takanashi M, Miyauchi T, Kakinuma Y, Goto K, Yamaguchi I.
    J Cardiovasc Pharmacol; 2004 Nov 23; 44 Suppl 1():S268-73. PubMed ID: 15838297
    [Abstract] [Full Text] [Related]

  • 13. Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.
    Smollich M, Götte M, Kersting C, Fischgräbe J, Kiesel L, Wülfing P.
    Breast Cancer Res Treat; 2008 Mar 23; 108(2):175-82. PubMed ID: 17468950
    [Abstract] [Full Text] [Related]

  • 14. Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells.
    Hunter AR, Turner AJ.
    Exp Biol Med (Maywood); 2006 Jun 23; 231(6):718-22. PubMed ID: 16740987
    [Abstract] [Full Text] [Related]

  • 15. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
    Rankin EB, Tomaszewski JE, Haase VH.
    Cancer Res; 2006 Mar 01; 66(5):2576-83. PubMed ID: 16510575
    [Abstract] [Full Text] [Related]

  • 16. Nitric oxide decreases the expression of endothelin-converting enzyme-1 through mRNA destabilization.
    Raoch V, Rodríguez-Pascual F, López-Martínez V, Medrano-Andrés D, Rodríguez-Puyol M, Lamas S, Rodríguez-Puyol D, López-Ongil S.
    Arterioscler Thromb Vasc Biol; 2011 Nov 01; 31(11):2577-85. PubMed ID: 21852564
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Downregulation of renal endothelin-converting enzyme 2 expression in early autoimmune diabetes.
    Ortmann J, Nett PC, Celeiro J, Hofmann-Lehmann R, Tornillo L, Terracciano LM, Barton M.
    Exp Biol Med (Maywood); 2006 Jun 01; 231(6):1030-3. PubMed ID: 16741043
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells.
    Jung JE, Lee HG, Cho IH, Chung DH, Yoon SH, Yang YM, Lee JW, Choi S, Park JW, Ye SK, Chung MH.
    FASEB J; 2005 Aug 01; 19(10):1296-8. PubMed ID: 15919761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.